Delivery of oligonucleotides: efficiency with lipid conjugation and clinical outcome

P Tran, T Weldemichael, Z Liu, H Li - Pharmaceutics, 2022 - mdpi.com
Oligonucleotides have shifted drug discovery into a new paradigm due to their ability to
silence the genes and inhibit protein translation. Importantly, they can drug the un-druggable …

Lipid conjugated oligonucleotides: a useful strategy for delivery

M Raouane, D Desmaële, G Urbinati… - Bioconjugate …, 2012 - ACS Publications
Oligonucleotides, including antisense oligonucleotides and siRNA, are promising
therapeutic agents against a variety of diseases. Effective delivery of these molecules is …

Oligonucleotide delivery: a patent review (2010–2013)

S Grijalvo, A Aviñó, R Eritja - Expert Opinion on Therapeutic …, 2014 - Taylor & Francis
Introduction: The use of aptamers, antisense technology and RNA interference has allowed
nucleic acids to be considered as promising alternatives to classical drugs. However …

Double-tailed lipid modification as a promising candidate for oligonucleotide delivery in mammalian cells

B Ugarte-Uribe, S Grijalvo, JV Busto, C Martín… - … et Biophysica Acta (BBA …, 2013 - Elsevier
Background The potential use of nucleic acids as therapeutic drugs has triggered the quest
for oligonucleotide conjugates with enhanced cellular permeability. To this end, the …

Lipid and peptide-oligonucleotide conjugates for therapeutic purposes: from simple hybrids to complex multifunctional assemblies

C Fàbrega, A Aviñó, N Navarro, AF Jorge, S Grijalvo… - Pharmaceutics, 2023 - mdpi.com
Antisense and small interfering RNA (siRNA) oligonucleotides have been recognized as
powerful therapeutic compounds for targeting mRNAs and inducing their degradation …

Recent preclinical and clinical advances in oligonucleotide conjugates

K Craig, M Abrams, M Amiji - Expert opinion on drug delivery, 2018 - Taylor & Francis
Introduction: Oligonucleotide therapeutics have the potential to change the way disease is
treated due to their ability to modulate gene expression of any therapeutic target in a highly …

Delivery of oligonucleotides with lipid nanoparticles

Y Wang, L Miao, A Satterlee, L Huang - Advanced drug delivery reviews, 2015 - Elsevier
Since their inception in the 1980s, oligonucleotide-based (ON-based) therapeutics have
been recognized as powerful tools that can treat a broad spectrum of diseases. The …

Lipid and polymeric carrier-mediated nucleic acid delivery

L Zhu, RI Mahato - Expert opinion on drug delivery, 2010 - Taylor & Francis
Importance of the field: Nucleic acids such as plasmid DNA, antisense oligonucleotide, and
RNA interference (RNAi) molecules, have a great potential to be used as therapeutics for the …

Lipid‐based nucleic acid therapeutics with in vivo efficacy

MA Sufian, MA Ilies - Wiley Interdisciplinary Reviews …, 2023 - Wiley Online Library
Synthetic vectors for therapeutic nucleic acid delivery are currently competing significantly
with their viral counter parts due to their reduced immunogenicity, large payload capacity …

Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles

K Bakowski, S Vogel - RNA biology, 2022 - Taylor & Francis
From the early days of research on RNA biology and biochemistry, there was an interest to
utilize this knowledge and RNA itself for therapeutic applications. Today, we have a series of …